With over Rs 1.03 lakh crore in investments registered till November 2023, the PLI scheme has witnessed significant traction, fostering…
WHO said in a statement that the nearly US$ 600 million in new funding includes US$ 180 million from the…
Wyost and Jubbonti have the same dosage form, route of administration, dosing regimen and presentation as the respective reference medicines.
Novo Nordisk’s widely used diabetes drug Ozempic delayed the progression of chronic kidney disease in diabetes patients, lowering the risk…
Vabysmo (faricimab) was first approved by the USFDA in January 2022.
These screenings should be done prior to discharge after a health-facility birth or at the first postnatal care contact in…
According to the norm, one hospital bed per 5,000 population is “essential” while 1 bed per 2,000 population is “desirable”.
The adoption of telehealth was accelerated by the pandemic, and this trend will continue to evolve.
The partnership with BostonGene will enable fast turnaround of next-generation sequencing (NGS) data, and sophisticated analytics will enable comprehensive profiling…
Cyient’s proven track record in delivering end-to-end solutions will empower MedTech companies to navigate the complexities of the healthcare market…
Influenza, commonly known as seasonal flu, is a highly contagious acute respiratory illness caused by influenza viruses.
Vitamin B12 Deficiency happens primarily due to poor lifestyle habits, dietary choices and medical conditions that hinder proper absorption and…
The Union Health Minister congratulated the Ministry of AYUSH for its remarkable journey in the last decade which has resulted…
These data are among a Zolgensma data set being presented during the 2024 Muscular Dystrophy Association (MDA) Clinical and Scientific…
Sandoz and Coherus entered into an agreement in January 2024 through which Sandoz agreed to acquire the full CIMERLI business…
There are over registered 40,000 hospitals in the country, which can now offer cashless facilities to all the health insurance…
Under the terms of the agreement, Biocon Biologics has secured a launch date for YESAFILI® 2 mg NDS for vials…
The success of Leqembi will likely be influenced by the success of its closest competitor, Eli Lilly’s anti- Aβ mAb…